Extracellular pyrophosphate metabolism and calcification in vascular smooth muscle.

Extracellular inorganic pyrophosphate (ePP(i)) is an important endogenous inhibitor of vascular calcification, but it is not known whether systemic or local vascular PP(i) metabolism controls calcification. To determine the role of ePP(i) in vascular smooth muscle, we identified the pathways responsible for ePP(i) production and hydrolysis in rat and mouse aortas and manipulated them to demonstrate their role in the calcification of isolated aortas in culture. Rat and mouse aortas contained mRNA for ectonucleotide pyrophosphatase/phosphodiesterases (NPP1-3), the putative PP(i) transporter ANK, and tissue-nonspecific alkaline phosphatase (TNAP). Synthesis of PP(i) from ATP in aortas was blocked by β,γ-methylene-ATP, an inhibitor of NPPs. Aortas from mice lacking NPP1 (Enpp1(-/-)) did not synthesize PP(i) from ATP and exhibited increased calcification in culture. Although ANK-mediated transport of PP(i) could not be demonstrated in aortas, aortas from mutant (ank/ank) mice calcified more in culture than did aortas from normal (ANK/ANK) mice. Hydrolysis of PP(i) was reduced 25% by β,γ-methylene-ATP and 50% by inhibition of TNAP. Hydrolysis of PP(i) was increased in cells overexpressing TNAP or NPP3 but not NPP1 and was not reduced in Enpp1(-/-) aortas. Overexpression of TNAP increased calcification of cultured aortas. The results show that smooth muscle NPP1 and TNAP control vascular calcification through effects on synthesis and hydrolysis of ePP(i), indicating an important inhibitory role of locally produced PP(i). Smooth muscle ANK also affects calcification, but this may not be mediated through transport of PP(i). NPP3 is identified as an additional pyrophosphatase that could influence vascular calcification.

[1]  W. C. O'Neill,et al.  Treatment with pyrophosphate inhibits uremic vascular calcification. , 2011, Kidney international.

[2]  A. Rosenthal,et al.  Parallel regulation of extracellular ATP and inorganic pyrophosphate: Roles of growth factors, transduction modulators, and ANK , 2011, Connective tissue research.

[3]  P. Ciancaglini,et al.  Proteoliposomes Harboring Alkaline Phosphatase and Nucleotide Pyrophosphatase as Matrix Vesicle Biomimetics , 2010, The Journal of Biological Chemistry.

[4]  P. Ciancaglini,et al.  Kinetic Analysis of Substrate Utilization by Native and TNAP-, NPP1-, or PHOSPHO1-Deficient Matrix Vesicles , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[5]  W. C. O'Neill,et al.  Plasma pyrophosphate and vascular calcification in chronic kidney disease. , 2010, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[6]  Brock T Brown,et al.  Discovery and validation of a series of aryl sulfonamides as selective inhibitors of tissue-nonspecific alkaline phosphatase (TNAP). , 2009, Journal of medicinal chemistry.

[7]  X. Chan,et al.  Identification and Characterization of Novel Tissue-Nonspecific Alkaline Phosphatase Inhibitors with Diverse Modes of Action , 2009, Journal of biomolecular screening.

[8]  G. Dubyak,et al.  Autocrine ATP release coupled to extracellular pyrophosphate accumulation in vascular smooth muscle cells. , 2009, American journal of physiology. Cell physiology.

[9]  J. Millán,et al.  Upregulation of alkaline phosphatase and pyrophosphate hydrolysis: potential mechanism for uremic vascular calcification. , 2008, Kidney international.

[10]  G. Yegutkin Nucleotide- and nucleoside-converting ectoenzymes: Important modulators of purinergic signalling cascade. , 2008, Biochimica et biophysica acta.

[11]  J. Millán,et al.  Novel Inhibitors of Alkaline Phosphatase Suppress Vascular Smooth Muscle Cell Calcification , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[12]  J. Sévigny,et al.  The E-NTPDase family of ectonucleotidases: Structure function relationships and pathophysiological significance , 2006, Purinergic Signalling.

[13]  D. Kingsley,et al.  Biochemical and genetic analysis of ANK in arthritis and bone disease. , 2006, American journal of human genetics.

[14]  M. Bollen,et al.  Modulation of purinergic signaling by NPP-type ectophosphodiesterases , 2006, Purinergic Signalling.

[15]  M. McKee,et al.  Unique coexpression in osteoblasts of broadly expressed genes accounts for the spatial restriction of ECM mineralization to bone. , 2005, Genes & development.

[16]  R. Terkeltaub,et al.  Chondrogenesis Mediated by PPi Depletion Promotes Spontaneous Aortic Calcification in NPP1−/− Mice , 2005, Arteriosclerosis, thrombosis, and vascular biology.

[17]  G. Dubyak,et al.  Methylene ATP analogs as modulators of extracellular ATP metabolism and accumulation , 2004, British journal of pharmacology.

[18]  W. C. O'Neill,et al.  Phosphate-induced vascular calcification: role of pyrophosphate and osteopontin. , 2004, Journal of the American Society of Nephrology : JASN.

[19]  P. Schauerte,et al.  PC-1 nucleoside triphosphate pyrophosphohydrolase deficiency in idiopathic infantile arterial calcification. , 2001, The American journal of pathology.

[20]  D. Kingsley,et al.  Role of the mouse ank gene in control of tissue calcification and arthritis. , 2000, Science.

[21]  J. Meyer,et al.  Can biological calcification occur in the presence of pyrophosphate? , 1984, Archives of biochemistry and biophysics.

[22]  H. Fleisch,et al.  Inhibition by pyrophosphate and polyphosphate of aortic calcification induced by vitamin D3 in rats. , 1968, Clinical science.